Research Article

Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction

Figure 2

Comparison of at baseline and 26 weeks after liraglutide introduction in patients with () and those with (). Changes in (a) in patients with and (b) in patients with . : wave to ratio on tissue Doppler echocardiography.
(a)
(b)